Home > Information > BioSpotlight

BioSpotlight

2025-01-21

Exploring Innovations in Bispecific Antibodies for Immunotherapy

Bispecific antibodies (BsAbs) are revolutionizing cancer and immunotherapy, with Merck & Co. investing $1.3 billion in CD19/CD3 BsAb CN201. Learn how BsAbs enhance immune activation and tumor elimination.
2025-01-21

Influenza, RSV: Key Proteins, Antibodies, and Research Solutions

Influenza and RSV cause seasonal outbreaks, posing risks to infants and the elderly. Key proteins like Hemagglutinin (HA), Neuraminidase (NA), and RSV Fusion Glycoprotein (F) are vital for vaccine and antiviral research. Abinscience offers recombinant proteins, antibodies, and ELISA kits to advance virology studies in diagnostics and therapeutics.
2025-01-21

Norovirus: Research Solutions with Proteins & Antibodies

Discover high-quality Norovirus research solutions, including recombinant proteins, antibodies. Learn about Norovirus structure, vaccine development, and diagnostics to advance your virology research.

Get a free quote